Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 7,500 shares at $28.50 ($214K) on 2022-03-30, disclosed to the SEC on 2022-04-01.
Open-market sale of $214k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |